Have a personal or library account? Click to login
A population-based study of the effectiveness of stereotactic ablative radiotherapy versus conventional fractionated radiotherapy for clinical stage I non-small cell lung cancer patients Cover

A population-based study of the effectiveness of stereotactic ablative radiotherapy versus conventional fractionated radiotherapy for clinical stage I non-small cell lung cancer patients

Radiology and Oncology
Volume 52 (2018): Issue 2 (June 2018)
By:
Open Access
|Dec 2017

References

  1. National Comprehensive Cancer Network Guideline for Non-Small Cell Lung Cancer, version 8. 2017. [Cited 14 Jul 2017]. Available at: <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf">https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf</ext-link>.
    Search in Google ScholarBack to article
  2. Baker S, Dahele M, Lagerwaard FJ, Senan S. A critical review of recent developments in radiotherapy for non-small cell lung cancer. <em>Radiat Oncol</em> 2016; <bold>11</bold>: 115. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1186/s13014-016-0693-8" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1186/s13014-016-0693-8</a></pub-id>
    Open DOISearch in Google ScholarBack to article
  3. Ricardi U, Badellino S, Filippi AR. Stereotactic body radiotherapy for early stage lung cancer: history and updated role. <em>Lung Cancer</em> 2015; <bold>90</bold>: 388-96. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/j.lungcan.2015.10.016" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.lungcan.2015.10.016</a></pub-id>
    Open DOISearch in Google ScholarBack to article
  4. Guckenberger M, Andratschke N, Alheit H, Holy R, Moustakis C, Nestle U, et al. Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer. <em>Strahlenther Onkol</em> 2014; <bold>190</bold>: 26-33. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1007/s00066-013-0450-y" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s00066-013-0450-y</a></pub-id>
    Open DOISearch in Google ScholarBack to article
  5. Murray P, Franks K, Hanna GG. A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer. <em>Br J Radiol</em> 2017; <bold>90</bold>: 20160732. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1259/bjr.20160732" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1259/bjr.20160732</a></pub-id>
    Open DOISearch in Google ScholarBack to article
  6. Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. <em>JAMA</em> 2010; <bold>303</bold>: 1070-6. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1001/jama.2010.261" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1001/jama.2010.261</a></pub-id>
    Open DOISearch in Google ScholarBack to article
  7. Chang JY, Senan S, Paul MA, Mehran RJ, Louie AV, Balter P, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. <em>Lancet Oncol</em> 2015; <bold>16</bold>: 630-7. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/S1470-2045(15)70168-3" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/S1470-2045(15)70168-3</a></pub-id>
    Open DOISearch in Google ScholarBack to article
  8. Dionisi F, Guarneri A, Dell’Acqua V, Leonardi M, Niespolo R, Macchia G, et al. Radiotherapy in the multidisciplinary treatment of liver cancer: a survey on behalf of the Italian Association of Radiation Oncology. <em>Radiol Med</em> 2016; <bold>121</bold>: 735-43. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1007/s11547-016-0650-5" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s11547-016-0650-5</a></pub-id>
    Open DOISearch in Google ScholarBack to article
  9. Matsuo Y, Yoshida K, Nishimura H, Ejima Y, Miyawaki D, Uezono H, et al. Efficacy of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis/inferior vena cava tumor thrombosis: evaluation by comparison with conventional three-dimensional conformal radiotherapy. <em>J Radiat Res</em> 2016; <bold>57</bold>: 512-23. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1093/jrr/rrw028" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/jrr/rrw028</a></pub-id>
    Open DOISearch in Google ScholarBack to article
  10. Nyman J, Hallqvist A, Lund J, Brustugun OT, Bergman B, Bergström P, et al. SPACE - a randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC. <em>Radiother Oncol</em> 2016; <bold>121</bold>: 1-8. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/j.radonc.2016.08.015" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.radonc.2016.08.015</a></pub-id>
    Open DOISearch in Google ScholarBack to article
  11. Wang SW, Ren J, Yan YL, Xue CF, Tan L, Ma XW. Effect of image-guided hypofractionated stereotactic radiotherapy on peripheral non-small-cell lung cancer. <em>Onco Targets Ther</em> 2016; <bold>9</bold>: 4993-5003. <pub-id pub-id-type="doi"><a href="https://doi.org/10.2147/OTT.S101125" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.2147/OTT.S101125</a></pub-id>
    Open DOISearch in Google ScholarBack to article
  12. Grutters JP, Kessels AG, Pijls-Johannesma M, De Ruysscher D, Joore MA, Lambin P. Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis. <em>Radiother Oncol</em> 2010; <bold>95</bold>: 32-40. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/j.radonc.2009.08.003" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.radonc.2009.08.003</a></pub-id>
    Open DOISearch in Google ScholarBack to article
  13. Jeppesen SS, Schytte T, Jensen HR, Brink C, Hansen O. Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates. <em>Acta Oncol</em> 2013; <bold>52</bold>: 1552-8. <pub-id pub-id-type="doi"><a href="https://doi.org/10.3109/0284186X.2013.813635" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.3109/0284186X.2013.813635</a></pub-id>
    Open DOISearch in Google ScholarBack to article
  14. Widder J, Postmus D, Ubbels JF, Wiegman EM, Langendijk JA. Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer. <em>Int J Radiat Oncol Biol Phys</em> 2011; <bold>81</bold>: e291-7. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/j.ijrobp.2011.03.052" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.ijrobp.2011.03.052</a></pub-id>
    Open DOISearch in Google ScholarBack to article
  15. Shirvani SM, Jiang J, Chang JY, Welsh JW, Gomez DR, Swisher S, et al. Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly. <em>Int J Radiat Oncol Biol Phys</em> 2012; <bold>84</bold>: 1060-70. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/j.ijrobp.2012.07.2354" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.ijrobp.2012.07.2354</a></pub-id>
    Open DOISearch in Google ScholarBack to article
  16. Liu HW, Gabos Z, Ghosh S, Roberts B, Lau H, Kerba M. Outcomes in stage I non-small cell lung cancer following the introduction of stereotactic body radiotherapy in Alberta - A population-based study. <em>Radiother Oncol</em> 2015; <bold>117</bold>: 71-6. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/j.radonc.2015.08.027" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.radonc.2015.08.027</a></pub-id>
    Open DOISearch in Google ScholarBack to article
  17. Lanni TB Jr, Grills IS, Kestin LL, Robertson JM. Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer. <em>Am J Clin Oncol</em> 2011; <bold>34</bold>: 494-8. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1097/COC.0b013e3181ec63ae" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1097/COC.0b013e3181ec63ae</a></pub-id>
    Open DOISearch in Google ScholarBack to article
  18. Mitera G, Swaminath A, Rudoler D, Seereeram C, Giuliani M, Leighl N, et al. Cost-effectiveness analysis comparing conventional versus stereotactic body radiotherapy for surgically ineligible stage I non-small-cell lung cancer. <em>J Oncol Pract</em> 2014; <bold>10</bold>: e130-6. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1200/JOP.2013.001206" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1200/JOP.2013.001206</a></pub-id>
    Open DOISearch in Google ScholarBack to article
  19. The Health and Welfare Data Science Center database (in Chinese). [Cited 18 Jul 2017]. Available at: <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://dep.mohw.gov.tw/DOS/np-2497-113.html">http://dep.mohw.gov.tw/DOS/np-2497-113.html</ext-link>.
    Search in Google ScholarBack to article
  20. Chiang CJ, You SL, Chen CJ, Yang YW, Lo WC, Lai MS. Quality assessment and improvement of nationwide cancer registration system in Taiwan: a review. <em>Jpn J Clin Oncol</em> 2015; <bold>45</bold>: 291-6. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1093/jjco/hyu211" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/jjco/hyu211</a></pub-id>
    Open DOISearch in Google ScholarBack to article
  21. Universal Health Coverage in Taiwan. [Cited 15 Jul 2017]. Available at
    Search in Google ScholarBack to article
  22. https://www.nhi.gov.tw/Resource/webdata/21717_1_UnversalHealthCoverage-2.pdf.
    Search in Google ScholarBack to article
  23. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. <em>Int J Surg</em> 2014; <bold>12</bold>: 1495-9. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/j.ijsu.2014.07.013" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.ijsu.2014.07.013</a></pub-id>
    Open DOISearch in Google ScholarBack to article
  24. Hsia TC, Tu CY, Fang HY, Liang JA, Li CC, Chien CR. Cost and effectiveness of image-guided radiotherapy for non-operated localized lung cancer: a population-based propensity score-matched analysis. <em>J Thorac Dis</em> 2015; <bold>7</bold>: 1643-9. <pub-id pub-id-type="doi"><a href="https://doi.org/10.3978/j.issn.2072-1439.2015.09.36" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.3978/j.issn.2072-1439.2015.09.36</a></pub-id>
    Open DOISearch in Google ScholarBack to article
  25. Chien CR, Pan IW, Tsai YW, Tsai T, Liang JA, Buchholz TA, et al. Radiation therapy after breast-conserving surgery: does hospital surgical volume matter? A population-based study in Taiwan. <em>Int J Radiat Oncol Biol Phys</em> 2012; <bold>82</bold>: 43-50. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/j.ijrobp.2010.09.025" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.ijrobp.2010.09.025</a></pub-id>
    Open DOISearch in Google ScholarBack to article
  26. Jelercic S, Rajer M. The role of PET-CT in radiotherapy planning of solid tumours. <em>Radiol Oncol</em> 2015; <bold>49</bold>: 1-9. <pub-id pub-id-type="doi"><a href="https://doi.org/10.2478/raon-2013-0071" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.2478/raon-2013-0071</a></pub-id>
    Open DOISearch in Google ScholarBack to article
  27. Schroeder MC, Tien YY, Wright K, Halfdanarson TR, Abu-Hejleh T, Brooks JM. Geographic variation in the use of adjuvant therapy among elderly patients with resected non-small cell lung cancer. <em>Lung Cancer</em> 2016; <bold>95</bold>: 28-34. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/j.lungcan.2016.02.010" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.lungcan.2016.02.010</a></pub-id>
    Open DOISearch in Google ScholarBack to article
  28. Austin PC. The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments. <em>Stat Med</em> 2014; <bold>33</bold>: 1242-58. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1002/sim.5984" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1002/sim.5984</a></pub-id>
    Open DOISearch in Google ScholarBack to article
  29. Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. <em>Stat Med</em> 2015; <bold>34</bold>: 3661-79. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1002/sim.6607" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1002/sim.6607</a></pub-id>
    Open DOISearch in Google ScholarBack to article
  30. Cole SR, Hernán MA. Adjusted survival curves with inverse probability weights. <em>Comput Methods Programs Biomed</em> 2004; <bold>75</bold>: 45-9. doi:<a href="https://doi.org/10.1016/j.cmpb.2003.10.004" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.cmpb.2003.10.004</a>
    Open DOISearch in Google ScholarBack to article
  31. Austin PC. Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis. <em>Stat Med</em> 2016; <bold>35</bold>: 5642-55. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1002/sim.7084" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1002/sim.7084</a></pub-id>.
    Open DOISearch in Google ScholarBack to article
  32. VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-Value. <em>Ann Intern Med</em> 2017; <bold>167</bold>: 268-74. <pub-id pub-id-type="doi"><a href="https://doi.org/10.7326/M16-2607" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.7326/M16-2607</a></pub-id>
    Open DOISearch in Google ScholarBack to article
  33. Garrido MM, Kelley AS, Paris J, Roza K, Meier DE, Morrison RS, et al. Methods for constructing and assessing propensity scores. <em>Health Serv Res</em> 2014; <bold>49</bold>: 1701-20. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1111/1475-6773.12182" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/1475-6773.12182</a></pub-id>
    Open DOISearch in Google ScholarBack to article
  34. Rosenbaum PR. Reasons for Effects. In: Rosenbaum PR, editor. Design of observational studies (Springer Series in Statistics). New York: Springer; 2010. p. 104-7. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1007/978-1-4419-1213-8" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/978-1-4419-1213-8</a></pub-id>
    Open DOISearch in Google ScholarBack to article
  35. Koshy M, Malik R, Weichselbaum RR, Sher DJ. Increasing radiation therapy dose is associated with improved survival in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer. <em>Int J Radiat Oncol Biol Phys</em> 2015; <bold>91</bold>: 344-50. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/j.ijrobp.2014.10.002" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.ijrobp.2014.10.002</a></pub-id>
    Open DOISearch in Google ScholarBack to article
  36. Chang JY, Bezjak A, Mornex F; IASLC Advanced Radiation Technology Committee. Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learned. <em>J Thorac Oncol</em> 2015; <bold>10</bold>: 577-85. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1097/JTO.0000000000000453" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1097/JTO.0000000000000453</a></pub-id>
    Open DOISearch in Google ScholarBack to article
  37. Ma BB, Hui EP, Mok TS. Population-based differences in treatment outcome following anticancer drug therapies. <em>Lancet Oncol</em> 2010; <bold>11</bold>: 75-84. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/S1470-2045(09)70160-3" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/S1470-2045(09)70160-3</a></pub-id>
    Open DOISearch in Google ScholarBack to article
  38. Wu YL, Zhong W, Wang Q, Xu ST, Mao WM, Wu L, et al. Gefitinib (G) versus vinorelbine+cisplatin (VP) as adjuvant treatment in stage II-IIIA (N1-N2) non-small-cell lung cancer (NSCLC) with EGFR-activating mutation (ADJUVANT): a randomized, Phase III trial (CTONG 1104). [Abstract]. 2017 ASCO Annual Meeting; <em>J Clin Oncol</em> 2017; <bold>35(15 Suppl)</bold>: 8500. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1200/JCO.2017.35.15_suppl.8500" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1200/JCO.2017.35.15_suppl.8500</a></pub-id>
    Open DOISearch in Google ScholarBack to article
DOI: https://doi.org/10.1515/raon-2017-0058 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 181 - 188
Submitted on: Jul 28, 2017
Accepted on: Sep 18, 2017
Published on: Dec 7, 2017
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
stereotactic ablative radiotherapy,
conventional fractionated radiotherapy,
non-small cell lung cancer
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2017 Chih-Yen Tu, Te-Chun Hsia, Hsin-Yuan Fang, Ji-An Liang, Su-Tso Yang, Chia-Chin Li, Chun-Ru Chien, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 52 (2018): Issue 2 (June 2018)Next article